Ferda Can
Overview
Explore the profile of Ferda Can including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Can F
Turk J Med Sci
. 2024 Dec;
54(7):1438-1446.
PMID: 39735486
The heart, as the main part of the circulatory system, is one of the organs frequently affected by hematological diseases. Cardiac problems may develop during the course and treatment of...
2.
Inci K, Aygencel G, Gokce O, Turkoglu M, Aydin Kaynar L, Can F, et al.
Ann Hematol
. 2024 Sep;
103(10):4239-4245.
PMID: 39235491
Background: The coexistence of sepsis and hematological malignancies increases patient vulnerability, revealing the need for precise prognostic markers. This study explores the prognostic significance of lactate levels and clearance in...
3.
Aydin M, Cengiz E, Can F, Dagdas S, Dilek I, Ozet G
Blood Res
. 2023 Nov;
58(4):234-237.
PMID: 37964656
No abstract available.
4.
Savas E, Yilmaz S, Baser Dikyar A, Ozkurt Z, Ocal R, Can F, et al.
Turk J Haematol
. 2023 Oct;
40(4):236-241.
PMID: 37877113
Objective: The discovery of imatinib was a milestone for chronic myeloid leukemia (CML). As the life expectancy of CML patients has approached that of the general population, research has shifted...
5.
Yuksel N, Koc S, Can F, Dilek I
J Curr Ophthalmol
. 2023 Sep;
35(1):100-102.
PMID: 37680280
Purpose: To report a case with an unusual giant mass in the eyelid which was diagnosed as peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). Methods: A 40-year-old woman was referred...
6.
Can F, Yilmaz K, Kosemehmetoglu O, Akinci S, Guney T
Ann Hematol
. 2023 Jul;
102(10):2645-2650.
PMID: 37432415
Iron deficiency anemia is the most common and preventable cause of anemia. Oral and parenteral iron preparations can be used for treatment. There are some concerns about the effect on...
7.
Simsek E, Karaca O, Cetinkaya F, Can F, Gunaydin S
Perfusion
. 2022 Dec;
39(2):436-438.
PMID: 36475516
Introduction: Cold agglutinin disease (CAD) is a rare autoimmune disorder characterized by destruction (hemolysis) of erythrocytes. In CAD, autoantibodies that cause agglutination at temperature of optimum +3-+4 ℃ degree cause...
8.
Aydin Kaynar L, Gokcen S, Can F, Yegin Z, Ozkurt Z, Yagci M
Ann Hematol
. 2022 Apr;
101(7):1459-1464.
PMID: 35460388
Iron-deficiency anemia (IDA) is accepted as the most common cause of anemia in the world. The main goals of iron replacement therapy are to normalize the hemoglobin level and to...
9.
Guney T, Can F, Akinci S, Kosemehmetoglu O, Dilek I
Turk J Haematol
. 2021 Dec;
39(1):74-75.
PMID: 34886748
No abstract available.
10.
Guney T, Can F, Alkan A, Akinci S, Dilek I
Clin Hemorheol Microcirc
. 2021 Oct;
80(3):233-240.
PMID: 34602461
Introduction: Essential thrombocythemia (ET) is an entity of classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), characterized by thrombocytosis with megakaryocytic hyperplasia where in the thrombocytes are increased with abnormal function.Thrombotic events...